Author:
Liu Xiao-ming,Peyton Kelly J.,Wang Xinhui,Durante William
Funder
National Institutes of Health
Subject
Pharmacology,Biochemistry
Reference52 articles.
1. Sildenafil: an orally active type 5 cyclic nucleotide cGMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction;Boolell;Int J Impot Res,1996
2. Phosphodiesterase-5 inhibitors: future perspectives;Konstantinos;Curr Pharm Des,2009
3. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular disease;Kukreja;Exp Clin Cardiol,2011
4. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of tuberculae carneae and aortic rings in vivo;Wallis;Am J Cardiol,1999
5. Expression, distribution and regulation of phosphodiesterase 5;Lin;Curr Pharm Des,2006
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献